Hint mode is switched on Switch off
For swift navigation between sections

VIVA Biotech Holdings
LEI 300300VJBVYQ6XJUKY15

PDF download

Choose all Reset all
Download Cancel
Organization name
VIVA Biotech Holdings
Country name
Hong Kong
Country of registration
Cayman Islands
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

VIVA Biotech Holdings is a China-based investment holding company. The Company is principally engaged in the provision of the structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide for their pre-clinical stage innovative drug development.

Awards

News

28/03/2024 Viva Biotech (1873.HK) Announces 2023 Annual Results: Successful Implementation of Light-asset Strategy, Achieving Solid Growth and Promising Future
20/11/2023 Viva Biotech Secures Approximately US$ 210 Million Funding
16/06/2023 Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million
All organization news

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    300300VJBVYQ6XJUKY15
  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Registration is required to get access.